Pharmacotherapy to counterACT parathion-induced NMJ dysfunction

对抗 ACT 对硫磷引起的 NMJ 功能障碍的药物治疗

基本信息

批准号：
8545988
负责人：
STEVEN B BIRD
金额：
$ 77.61万
依托单位：
UNIV OF MASSACHUSETTS MED SCH WORCESTER
依托单位国家：
美国
项目类别：
财政年份：
2013
资助国家：
美国
起止时间：
2013-09-01 至 2017-08-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8545988
关键词：
Acetylcholinesterase Acute Affect Animal Model Animals Antidotes Appearance Architecture Area Atropine Benzodiazepines Chemical Warfare Clinical effectiveness Complication Cranial Nerves Critical Care Effectiveness Electromyography Environmental air flow Exercise Failure Functional disorder Goals Grant Hour Human Imaging Techniques Intensive Care Interdisciplinary Study Intervention Intratracheal Intubation Investigation Laboratories Limb structure Measures Mechanical ventilation Medical Methods Modeling Morbidity - disease rate Muscarinics Muscle NIH Program Announcements Neurologic Neuromuscular Junction Neuropathy Nicotinic Receptors Norepinephrine Oximes Paralysed Parathion Patients Pesticides Pharmacotherapy Physiological Physiology Poisoning Procedures Public Health Rattus Recovery Research Resolution Respiratory Failure Respiratory Muscles Resuscitation Rotarod Performance Test Structure Syndrome Toxic effect Vasoconstrictor Agents Work cholinergic clinical application clinically relevant conventional therapy evidence base experience grasp improved in vivo innovation molecular imaging mortality muscle strength neuromuscular transmission neurophysiology novel pesticide poisoning public health relevance

项目摘要

DESCRIPTION (provided by applicant): The acute toxicity of OPs is primarily due to inhibition of acetylcholinesterase (AChE). Current therapy for OP poisoning requires resuscitation with the use of atropine, followed by administration of oximes to reactivate AChE, and benzodiazepines to mitigate neurological complications. However, these antidotes have limited effectiveness and between 10 and 40% of patients, depending on the responsible OP, still die even with intensive care support. Furthermore, acute failure of neuromuscular transmission leads to respiratory failure and profound weakness. This failure of the neuromuscular junction (NMJ) has recently been shown to occur within hours after severe poisoning. The purpose of this grant is to determine the physiologic and immunohistochemical efficacy of the nicotinic receptor antagonist pancuronium in preserving NMJ function and NMJ architecture in a novel rat model of parathion poisoning. This model will mimic the Intermediate Syndrome and consist of intensive care treatment with comprehensive medical therapy, including mechanical ventilation, atropine, 2-PAM, benzodiazepines, and vasopressors. Our central hypothesis is that pharmacologic targeting of the NMJ with pancuronium will improve muscle strength and NMJ structure in a rat model of acute parathion poisoning. Lastly, while these studies are critically applicable to chemical warfare and mass casualty situations, they are also applicable to isolated cases of severe OP poisoning that occur every day in the U.S. and abroad.

描述（由申请人提供）：OP的急性毒性主要是由于抑制乙酰胆碱酯酶（ACHE）。当前对OP中毒的疗法需要使用阿托品使用阿托品，然后使用氧气重新激活ACHE，而苯二氮卓类药物则可以减轻神经系统并发症。但是，这些解毒剂的有效性有限，在10％到40％的患者中，取决于负责的OP，即使在重症监护支持下仍然死亡。此外，神经肌肉传播的急性衰竭会导致呼吸衰竭和严重的虚弱。神经肌肉连接（NMJ）的这种失败最近被证明在严重中毒后数小时内发生。这项赠款的目的是确定烟碱受体拮抗剂胰腺在新型大鼠中毒模型中保存NMJ功能和NMJ结构中烟碱受体拮抗剂胰腺的生理和免疫组织化学功效。该模型将模仿中间综合症，并包括接受全面的医疗疗法的重症监护治疗，包括机械通气，阿托品，2-PAM，苯并二氮卓类药物和加速器。我们的中心假设是，在急性parathion中毒大鼠模型中，用胰腺对NMJ的药理靶向将改善肌肉强度和NMJ结构。最后，尽管这些研究非常适用于化学战和大规模伤亡情况，但它们也适用于每天在美国和国外发生的严重OP中毒病例。